ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 630511 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 630511; 2) Community: the network communities that were significantly associated with the response to NSC 630511; 3) Molecule: the relationships between components within communities and NSC 630511; 4) MDR: the compounds that were significantly associated with the NSC 630511.

NSC Compound Enrichment Correlation
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.00744479268267747 0.5599183
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00744479268267747 0.24509408
NSC 745923 Null 0.00744479268267747 0.33604496
NSC 745957 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide 0.00744479268267747 0.40281485
NSC 746248 Null 0.00744479268267747 0.31422401
NSC 84145 Null 0.00744479268267747 0.18076429
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.00845932736945067 0.76699129
NSC 641394 1H-Benzo[a]carbazole-1,4(11H)-dione, 11-phenyl- 0.00845932736945067 0.78421518
NSC 648322 Incarnal 0.00845932736945067 0.75639
NSC 664951 Null 0.00845932736945067 0.77864315
Total:104  Current:31    [First] [Prev] [Next] [Last]